Galen Femring Includes HRT Class Labeling; Launch In June
Executive Summary
Labeling for Galen's vaginal hormone therapy Femring follows the template established for Wyeth's Premarin family to incorporate the findings from NIH's Women's Health Initiative study
You may also be interested in...
Warner Chilcott Femtrace Launch Expected In First Quarter 2005
Warner Chilcott is planning an early 2005 launch for Femtrace following FDA approval of the hormone replacement therapy Aug. 20
Warner Chilcott Femtrace Launch Expected In First Quarter 2005
Warner Chilcott is planning an early 2005 launch for Femtrace following FDA approval of the hormone replacement therapy Aug. 20
Galen in play
Merger talks between women's health specialty company Galen and unidentified suitor (reportedly Barr) terminated July 21. Galen has recently expanded its product line via acquisition of Pfizer's women's health brands, Lilly's pre-menstrual dysphoric disorder agent Sarafem and the approval of Femring (1"The Pink Sheet" March 31, 2003, p. 29)...